Search Results - "Wattecamps, Guilhem"
-
1
Attributable mortality of ICU acquired bloodstream infections: a propensity-score matched analysis
Published in European journal of clinical microbiology & infectious diseases (01-08-2021)“…The mortality attributable to ICU-acquired bloodstream infection (BSI) differs between studies due to statistical methods used for cohort matching…”
Get full text
Journal Article -
2
Remdesivir plus standard of care versus standard of care alone for the treatment of patients admitted to hospital with COVID-19 (DisCoVeRy): a phase 3, randomised, controlled, open-label trial
Published in The Lancet infectious diseases (01-02-2022)“…The antiviral efficacy of remdesivir against SARS-CoV-2 is still controversial. We aimed to evaluate the clinical efficacy of remdesivir plus standard of care…”
Get full text
Journal Article -
3
Multiple-site decontamination regimen without systemic antibiotics associated with reduced mortality in intubated patients
Published in Infectious diseases (London, England) (02-07-2020)Get full text
Journal Article -
4
Final results of the DisCoVeRy trial of remdesivir for patients admitted to hospital with COVID-19
Published in The Lancet infectious diseases (01-06-2022)“…Eligible participants were adults (aged ≥18 years) who were admitted to hospital with a positive PCR test for SARS-CoV-2 (<72 h before randomisation) and also…”
Get full text
Journal Article -
5
Cardiac Adverse Events and Remdesivir in Hospitalized Patients With COVID-19: A Post Hoc Safety Analysis of the Randomized DisCoVeRy Trial
Published in Clinical infectious diseases (16-08-2024)“…We aimed to evaluate the cardiac adverse events (AEs) in hospitalized patients with coronavirus disease 2019 (COVID-19) who received remdesivir plus standard…”
Get full text
Journal Article -
6
Cardiac Adverse Events and Remdesivir in Hospitalized Patients with Coronavirus Disease 2019 (COVID-19): A Post Hoc Safety Analysis of the Randomized DisCoVeRy Trial
Published in Clinical infectious diseases (29-03-2024)“…Background We aimed to evaluate the cardiac adverse events (AEs) in hospitalized patients with Coronavirus Disease 2019 (COVID-19) receiving remdesivir plus…”
Get full text
Journal Article -
7
Multiple-site decontamination in mechanically ventilated ICU patients: A real-life study
Published in Infectious diseases now (Online) (01-04-2023)“…•Multiple site decontamination (MSD) decreases the risk of ICU-acquired infection.•VAP and BSI incidences were lower in patients receiving MSD.•There was no…”
Get full text
Journal Article